DOI QR코드

DOI QR Code

ICR 마우스를 이용한 Bacillus subtilis JNS 균주의 단회경구투여 독성시험

Single Dose Oral Toxicity of Bacillus subtilis JNS in ICR Mice

  • 김경훈 ((주)제이엔에스텍) ;
  • 정창화 ((주)제이엔에스텍) ;
  • 주성제 (동의대학교 생명응용학과) ;
  • 박종훈 (동의대학교 생명응용학과) ;
  • 문지영 (동의대학교 생명응용학과) ;
  • 조은지 (동의대학교 생명응용학과) ;
  • 이현태 (동의대학교 생명응용학과) ;
  • 권현주 (동의대학교 생명응용학과) ;
  • 김병우 (동의대학교 생명응용학과) ;
  • 엄성환 (한국식품연구원 소재연구센터) ;
  • 이은우 (동의대학교 생명응용학과)
  • Kim, Kyoung-Hoon (JNS Tech Co.) ;
  • Jeong, Chang Hwa (JNS Tech Co.) ;
  • Joo, Seong-Je (Department of Life Science and Biotechnology, Dongeui University) ;
  • Park, Jong-Hoon (Department of Life Science and Biotechnology, Dongeui University) ;
  • Moon, Ji-Young (Department of Life Science and Biotechnology, Dongeui University) ;
  • Cho, Eun-Ji (Department of Life Science and Biotechnology, Dongeui University) ;
  • Lee, Hyun-Tai (Department of Life Science and Biotechnology, Dongeui University) ;
  • Kwon, Hyun-Ju (Department of Life Science and Biotechnology, Dongeui University) ;
  • Kim, Byung-Woo (Department of Life Science and Biotechnology, Dongeui University) ;
  • Eom, Sung-Hwan (Food Resource Research Center, Korea Food Research Institute) ;
  • Lee, Eun-Woo (Department of Life Science and Biotechnology, Dongeui University)
  • 투고 : 2014.08.27
  • 심사 : 2014.12.08
  • 발행 : 2015.01.31

초록

청국장에서 분리한 항균활성이 우수한 Bacillus subtilis JNS의 probiotics로서의 활용성을 검증하기 위해 단기투여에 의한 안전성을 확인하고자 실험을 실시하였다. 경구투여용 존데를 이용하여 임상적용 경로인 경구로 투여하였으며, 최고투여용량은 2,000 mg/kg으로 설정하였다. ICR계 암수 마우스에서 14일간 관찰한 결과 일반증상, 사망률, 체중, 임상증상 및 육안적 소견 등에서 무처리 대조군과 비교해서 유의성 있는 차이를 보이지 않았다. 부검 후의 주요 장기에 대한 육안적 검사에서 또한 대조군과 비교하여 이상소견이나 병변이 관찰되지 않았다. 이상의 결과로부터 시험물질인 B. subtilis JNS는 경구투여 시 ICR계 암수 마우스에서 독성학적인 변화가 관찰되지 않았으며, 경구투여가 2,000 mg/kg 이상인 저독성의 안전한 물질로 사료된다.

The present study was carried out to investigate the in vivo single-dose acute toxicity of Bacillus subtilis JNS isolated from Cheonggukjang, which is a probiotic candidate showing strong and broad antibacterial activity. The test sample was orally administrated to male and female ICR mice at a highest dose of 2,000 mg/kg for 14 days. No significant change in general conditions, mortalities, body weight changes, clinical signs, autopsy findings, or presence of gross lesions was observed in either sex of mice. The results indicate that up to 2,000 mg/kg of B. subtilis JNS had no adverse effect on ICR mice.

키워드

참고문헌

  1. de Roos NM, Katan MB. 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr Rev 71: 405-411.
  2. Homma N. 1998. Bifidobacteria as a resistance factor in human beings. Bifodobact Microflora 7: 35-43.
  3. Donohue DC, Salminen S. 1996. Safety of probiotic bacteria. Asia Pacific J Clin Nutr 5: 25-28.
  4. Shin HJ, Bang JH, Choi HJ, Kim DW, Ahn CS, Jeong YK, Joo WH. 2012. Probiotic potential of indigenous Bacillus sp. BCNU 9028 isolated from meju. J Life Sci 22: 605-612. https://doi.org/10.5352/JLS.2012.22.5.605
  5. Lee YL, Kim SH, Jung NH, Lim MH. 1992. A study on the production of viscous substance during the chungkookjang fermentation. J Korean Agric Chem Soc 35: 202-209.
  6. Lee MJ, Lee YG, Cho JI, Na KC, Kim MS, Moon HJ. 2014. Antioxidative activity of cheonggukjang prepared with purple sweet potato. Korean J Food Sci Technol 46: 224-230. https://doi.org/10.9721/KJFST.2014.46.2.224
  7. Lee BY, Kim DM, Kim KI. 1991. Physico-chemical properties of viscous substance extracted from chungkook-jang. Korean J Food Sci Technol 23: 599-604.
  8. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC. 2001. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45: 3156-3161. https://doi.org/10.1128/AAC.45.11.3156-3161.2001
  9. Cutting SM. 2010. Bacillus probiotics. Food Microbiol 28: 214-220.
  10. Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, Cutting SM. 1999. Characterization of two Bacillus probiotics. Appl Environ Microbiol 65: 4288-4291.
  11. KFDA. 2013. Guidelines for toxicity tests of drugs and related materials notification. Korea Food and Drug Administration, Cheongju, Korea. p 7.
  12. Kim KH, Cho EJ, Joo SJ, Park JH, Chung JM, Jeong CH, Kim BW, Lee EW. 2013. Properties of of Bacillus subtilis JNS, a candidate of probiotic, isolated from fermented soybean food in Korea. Proceeding of the 2013 Conference of the Korean Society for Microbiology and Biotechnology. Gyeongju, Korea. p 36.
  13. Lim JH, Park BK, Kim MS, Rhee MH, Park SC, Yun HI. 2004. Acute oral toxicity and pathogenicity of a potential probiotic Bacillus sp. A9184 isolated from soybean paste. J Toxicol Pub Health 20: 359-363.
  14. Hwang MH, Kim YH, Kim EY, Song JC, Lee KW, Jeong KS, Kim KS, Rhee M, Kwon OD, Yun HI, Kim JC, Park SC. 2004. Pathogenicity and single dose toxicity of a potential probiotic Lactobacillus spp. PSC101 in mice. J Toxicol Pub Health 20: 173-177.
  15. Lee H, Cha SS, Lee MY, Chang HC, Lee JJ. 2013. Acute toxicity of Leuconostoc citreum GR1 isolated from kimchi in mice. Korean J Food Preserv 20: 121-126. https://doi.org/10.11002/kjfp.2013.20.1.121
  16. Guo X, Li D, Lu W, Piao X, Chen X. 2006. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Antonie Van Leeuwenhoek 90: 139-146. https://doi.org/10.1007/s10482-006-9067-9

피인용 문헌

  1. Genotoxicological Safety Evaluation of Crude Antifungal Compounds Produced by Bacillus subtilis SN7 vol.28, pp.1, 2017, https://doi.org/10.7856/kjcls.2017.28.1.131
  2. Single Oral Dose Toxicity Test and Four Weeks Repeated Oral Dose Determination Test of Crude Antifungal Compounds Produced by Bacillus subtilis SN7 in Rats vol.27, pp.3, 2016, https://doi.org/10.7856/kjcls.2016.27.3.437